| Similar Articles |
|---|
 |
Pharmaceutical Executive
March 1, 2011
Andrea LaFountain |
Where have all the Scientists Gone? With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence.   |
Pharmaceutical Executive
August 1, 2012
Wendy Balter |
New Approaches to Medical Education Planning Promotional medical education planning used to be able to focus on the science first, without much consideration for delivery channels. Now technology expertise and channel considerations demand an equal share in up-front planning. |
Pharmaceutical Executive
February 1, 2007
Iaquinto & Palmisano |
Medical Education: A Platform for Success By pumping the science behind a brand, pharmaceutical companies can garner early loyalist - before a drug even hits the market. |
Pharmaceutical Executive
June 1, 2011 |
Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity? |
Search Engine Watch
April 24, 2009
Chris Boggs |
Performance Management for SEO Teams Disciplined companies that are able to drive efficiencies through performance reviews and goal-setting can get an edge in SEO as well. |
Pharmaceutical Executive
June 1, 2006
Paul Kidwell |
Public Relations: Targeting Partners PR can facilitate business partnerships between biotechnology and pharmaceutical companies by targeting messages to key players. |
Pharmaceutical Executive
June 1, 2007
Michael Goodman |
A Very Specialty Moment Big Pharma is on a shopping spree for biologics and other specialty products. It has the money to buy them. But does it have the mojo to develop and market them successfully - or will the mid-size biopharmas make their big move? |
Pharmaceutical Executive
January 1, 2009
Stan Bernard |
Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms. |
Pharmaceutical Executive
October 1, 2005
Chaudhry & Love |
Key Opinion Leaders Interactions with Pharma Big pharmaceutical companies are paying the same key opinion leaders for many different services. All at the same time. And firms don't notice it because key opinion leaders are hidden in silos. |
Pharmaceutical Executive
July 30, 2007
Stewart Young |
Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds. |
Pharmaceutical Executive
August 1, 2005
Richard B. Vanderveer |
Position, Position, Position The "weekender," the "doughnut hole," and the secret art of "bathroom mapping": How pharma marketers are learning to tell new stories for every phase of a drug's lifecycle. |
Pharmaceutical Executive
June 1, 2005
Ian Wilcox |
Raising Renaissance Managers The leaders of pharma lack vision because of the industry's practice of promoting specialists to top positions. Talent management strategies can reverse this trend and lead to greater success. |
Information Today
December 15, 2015
Abby Clobridge |
Introducing Meta: Where Big Science Meets Scientific Publishing All of Meta's services are created around its machine intelligence platform, which reads more than 19 million full-text articles, the entirety of PubMed, and continuously crawls the web to identify all of the people and entities mentioned in the literature. |
Bio-IT World
August 13, 2002
Mark D. Uehling |
Clinical Trial Data Management: Tortured by Paper Reams of paper stuffed into boxes and shipped to the FDA by the truckload is hardly the best approach to drug approval. But what's the right way? |
Information Today
February 25, 2008 |
Thomson Scientific to Use Collexis' Knowledge Dashboard in Custom Solution Plans to join Collexis' Knowledge Dashboard with Thomson Scientific's Web of Science will create a custom data mining solution for the research community. |
D-Lib
June 2006
Wojick et al. |
The Digital Road to Scientific Knowledge Diffusion: A Faster, Better Way to Scientific Progress? A discussion of issues and description of research being conducted by the Office of Scientific and Technical Information of the United States Department of Energy under its strategic initiative, Innovations in Scientific Knowledge and Advancement. |
Information Today
December 8, 2011 |
Reprints Desk Announces Journal Article Web App `Bibliogo' Bibliogo is a mashup for everything you want to do with articles. It combines aspects from personalized RSS readers and alerting services, bibliographic reference management software, daily deal websites for clinical reprints, and document delivery management systems |
Bio-IT World
March 10, 2003
Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
Managed Care
February 2002
Ira Studin |
Reframing the Pharmaceutical Manufacturer/Health Plan Relationship in Managed Care It is suggested that health plans address "total cost-of-care savings" in their budget process, and the pharmaceutical manufacturers establish a "consultative service function" in their managed care divisions... |
D-Lib
October 2007
Anna Gold |
Cyberinfrastructure, Data, and Libraries, Part 1: A Cyberinfrastructure Primer for Librarians Librarians interested in what their roles will be in the future cyberinfrastructures of science may find their skills and capabilities give them a natural and even crucial role in building and supporting the information infrastructures of local data centers. |
Chemistry World
October 22, 2013
Andy Roast |
Science communication: a practical guide for scientists This book by Bowater and Yeoman begins with the emergence and importance of science communication, providing many good reasons for engaging the public with scientific research. |
D-Lib
Nov/Dec 2014
Kroll et al. |
Towards a Marketplace for the Scientific Community: Accessing Knowledge from the Computer Science Domain As scientific output is constantly growing, it is getting more and more important to keep track not only for researchers but also for other scientific stakeholders such as funding agencies or research companies |
Pharmaceutical Executive
October 1, 2005
Lisa Grimes |
Clear Road Ahead An industry standard for publicizing clinical-trial results is a ways off. But pharma's openness to more transparent procedures is moving things in the right direction. |
Chemistry World
November 7, 2011
Eugene Gerden |
Russia Books Place at Science Top Table The Innovative Russia 2020 scheme should see science funding rise to at least 2.5 per cent of GDP. However, some critics think the scheme is overambitious and predict that implementation will run into bureacratic problems. |
Bio-IT World
April 16, 2004
Joel Hoffman |
Taking the Trial Out of Clinical Outsourcing Make sure the vendor's standard operating procedures will mesh with your own, and then tirelessly work toward systems integration. |
HBS Working Knowledge
July 16, 2012
Cynthia A. Montgomery |
Book Excerpt: The Strategist It's time for CEOs to start reclaiming strategy as a key executive responsibility, a new book, "The Strategist." |
Chemistry World
February 12, 2015
S Umapathy |
Indian science at the crossroads How should Indian scientific research evolve? |
Chemistry World
October 16, 2014
John Ioannidis |
Not all science is created equal The way the scientific method is implemented and the standards of research in each discipline can vary substantially. |
Science News
July 1, 2000 |
Herbal Activity Website provides scientific and general information about the biochemical activity of a variety of herbs. |
Pharmaceutical Executive
January 1, 2007
Glass & Poli |
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. |
